Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank 薬物名（臨床試験情報から抽出） KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Atovaquone 1件: Atovaquone1件: Atovaquone (ATOVAQUONE ORAL SUSPENSION) 💬 --1件: 61 💬
2 Caffeine 1件: Caffeine3件: Caffeine ,
Caffeine hydrate ,
Caffeine citrate (CAFFEINE CITRATE ORAL SOLUTION) 💬 		11件: ADORA1,
ADORA2A,
PDE1,
PDE2A,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PDE5 💬 		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 2, 6, 13, 21, 46, 96, 97, 265 💬
3 Cetirizine 3件: Cetirizina; Cetirizine; Cetirizine hydrochloride2件: Cetirizine hydrochloride (CETIRIZINE HYDROCHLORIDE ORAL SOLUTION),
Cetirizine 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬6件: 13, 19, 28, 35, 300, 309 💬
4 Chlorhexidine 2件: Chlorhexidine; Chlorhexidine gluconate4件: Chlorhexidine gluconate (ACCLEAN CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, CHLORHEXIDINE GLUCONATE ORAL RINSE, CHLORHEXIDINE GLUCONATE, 0.12% ORAL RINSE, CHLORHEXIDINE GLUCONATE, 0.12% ORAL RINSE SOLUTION, CLEANCARE CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, DASH CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, MAJOR ORAL RINSE, SKY ORAL RINSE),
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate 💬 		--2件: 86, 299 💬
5 Deferasirox 1件: Deferasirox1件: Deferasirox (DEFERASIROX ORAL, DEFERASIROX ORAL GRANULES) 💬 --4件: 54, 254, 284, 286 💬
6 Deflazacort 1件: Deflazacort1件: Deflazacort (DEFLAZACORT ORAL SUSPENSION) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 30, 113 💬
7 Enalapril 2件: Enalapril; Enalapril maleate2件: Enalapril maleate (ENALAPRIL MALEATE ORAL SOLUTION),
Enalapril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬8件: 13, 19, 46, 66, 113, 210, 222, 279 💬
8 Escitalopram 3件: Citalopram; Escitalopram; Escitalopram oxalate2件: Escitalopram oxalate (ESCITALOPRAM ORAL SOLUTION),
Escitalopram 💬 		1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬5件: 2, 6, 13, 46, 77 💬
9 Fentanyl 1件: Fentanyl3件: Fentanyl ,
Fentanyl citrate (Oralet),
Fentanyl hydrochloride 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬6件: 46, 70, 97, 215, 231, 298 💬
10 Glycopyrronium 1件: Glycopyrrolate3件: Glycopyrrolate (GLYCOPYRROLATE ORAL SOLUTION),
Glycopyrronium ,
Glycopyrronium tosylate 💬 		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬2件: 6, 34 💬
11 Itraconazole 1件: Itraconazole1件: Itraconazole (ITRACONAZOLE ORAL) 💬 --8件: 2, 3, 46, 65, 96, 97, 227, 299 💬
12 Lacosamide 1件: Lacosamide1件: Lacosamide (LACOSAMIDE ORAL SOLUTION) 💬 2件: SCN3A,
SCN9A 💬 		1件: Taste transduction 💬4件: 2, 46, 149, 298 💬
13 Metformin 3件: Metformin; Metformin hydrochloride; Metformina2件: Metformin hydrochloride (METFORMIN HYDROCHLORIDE ORAL SOLUTION),
Metformin 💬 		2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬28件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 222, 225, 265, 285, 298, 299, 301 💬
14 Naproxen 3件: Naproxen; Naproxen sodium; Propanoic acid2件: Naproxen (NAPROXEN ORAL SUSPENSION),
Naproxen sodium 💬 		2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 13, 46, 107, 271 💬
15 Nitrofurantoin 1件: Nitrofurantoin1件: Nitrofurantoin (NITROFURANTOIN ORAL SUSPENSION) 💬 --1件: 13 💬
16 Oseltamivir 1件: Oseltamivir2件: Oseltamivir phosphate (OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSION),
Oseltamivir 💬 		--2件: 97, 299 💬
17 Oxycodone 2件: Oxycodone; Oxycodone hydrochloride3件: Oxycodone hydrochloride (OXYCODONE HYDROCHLORIDE ORAL SOLUTION),
Oxycodone terephthalate ,
Oxycodone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬6件: 6, 46, 70, 226, 231, 298 💬
18 Potassium chloride 1件: Potassium chloride1件: Potassium chloride (POTASSIUM CHLORIDE FOR ORAL SOLUTION) 💬 --1件: 97 💬
19 Sevelamer 1件: Sevelamer3件: Sevelamer hydrochloride ,
Sevelamer carbonate (SEVELAMER CARBONATE FOR ORAL SUSPENSION),
Sevelamer 💬 		--2件: 235, 238 💬
20 Triamcinolone 3件: Triamcinolone; Triamcinolone acetonide; Triamcinolone hexacetonide4件: Triamcinolone ,
Triamcinolone acetonide (ORALONE),
Triamcinolone diacetate ,
Triamcinolone hexacetonide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬10件: 35, 46, 53, 56, 70, 90, 96, 107, 226, 298 💬
21 Valganciclovir 1件: Valganciclovir2件: Valganciclovir ,
Valganciclovir hydrochloride (VALGANCICLOVIR HYDROCHLORIDE FOR ORAL) 💬 		--6件: 28, 60, 85, 97, 299, 331 💬
22 Vancomycin 1件: Vancomycin2件: Vancomycin ,
Vancomycin hydrochloride (VANCOMYCIN HYDROCHLORIDE FOR ORAL SOLUTION) 💬 		--8件: 13, 46, 70, 94, 96, 97, 296, 299 💬
23 Vigabatrin 1件: Vigabatrin1件: Vigabatrin (VIGABATRIN FOR ORAL SOLUTION) 💬 1件: ABAT 💬 6件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬2件: 145, 158 💬